One P variant and six VUS MMR genes (MLH1, MSH2, MSH6 and PMS2) were identified in patients with multiple primary cancers (pancreatic, colorectal, gastric, bladder, cervical, esophageal, lung, skin and thyroid cancers). This evidence concerns the gene MLH1 and thyroid cancer.